Reichmuth & Co is one of the pioneers of non-mandatory pension solutions in Switzerland. We are by our clients’ side with our more than 25 years of expertise in finance and pensions.
Together with our subsidiary, we have been offering innovative and customized solutions for the tax-privileged accumulation and management of your retirement assets for 25 years.
Watch the story of “Opportunities and Willpower” in this short video. Enjoy!
«As an innovative and digitally savvy employer, we wanted to offer our employees a modern pension solution. Today, this is an asset when it comes to recruiting new talent.»
«We decided to use our occupational benefits account to finance our mortgage. This interesting option allows us to take advantage of deductible interest payments which will ultimately flow back into our pension assets.»
«Thanks to early pension planning, I now have a clear overview of the things I have to do to optimise my finances for my impending retirement. That makes me feel secure and at ease.»
As part of a broad-based initiative to strengthen personal responsibility in the banking sector, a guest article entitled “Haften statt retten” (Liability instead of rescue) was published in the Neue Zürcher Zeitung (NZZ) on September 1, 2025. The article was written by Christian Bidermann, partner at Rahn & Bodmer and Jürg Staub, general partner at Reichmuth & Co.
Switzerland is sitting on a ticking currency time bomb: the Swiss franc. What has been regarded as a sign of stability and solidity for years could prove highly explosive in the event of a new global economic shock. While the Swiss Confederation shines as a safe haven with one of the lowest debt ratios in the world and a credible monetary stability policy pursued by the SNB, it is precisely this status that threatens to become a challenge.
The pharmaceutical industry is currently high on Donald Trump’s list of priorities. He wants more production and jobs in the US, as well as lower drug prices. As a means of exerting pressure, he is threatening to impose price caps and introduce tariffs on drugs. These goals are, of course, contradictory, which is causing even more uncertainty.